Stock Groups

Henry Schein Earnings, Revenue Beat in Q3 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Henry Schein Earnings, Revenue Beat in Q3

Investing.com Henry Schein (NASDAQ: ) On Tuesday, the third quarter ended with revenue surpassing expectations. Analysts’ estimates were exceeded.

Henry Schein declared earnings per share (EPS) of $1.1 on revenues of $3.18B. Investing.com polled analysts and predicted EPS at $0.9399 for revenue of $2.94B.

Henry Schein shares rose 14% over the first of the year but are down 8.85% from its 52-week peak of $83.45, which was set May 10. The Nasdaq is performing better than them, which has risen 21.01% since the beginning of the year.

Henry Schein is following other notable earnings in the Healthcare sector this month

Henry Schein’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Thermo Fisher Scientific beat all expectations with a third quarter EPS at $5.76 on revenues of $9.33B. This compares to EPS forecasted for $4.68 on revenues of $8.38B.

You can keep up-to date on the latest earnings reports by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]